THE CELLULAR BASIS FOR LACK OF ANTIBODY-RESPONSE TO HEPATITIS-B VACCINE IN HUMANS

被引:123
作者
EGEA, E
IGLESIAS, A
SALAZAR, M
MORIMOTO, C
KRUSKALL, MS
AWDEH, Z
SCHLOSSMAN, SF
ALPER, CA
YUNIS, EJ
机构
[1] CTR BLOOD RES INC,800 HUNTINGTON AVE,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV IMMUNOGENET,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
[4] BETH ISRAEL HOSP,BOSTON,MA 02215
[5] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1084/jem.173.3.531
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We had previously obtained evidence that among normal subjects the humoral antibody response to hepatitis B surface antigen (HBsAg) was bimodally distributed with about 14% of subjects producing < 1,000 estimated radioimmunoassay RIA units. From the study of major histocompatibility complex (MHC) markers in the very poor responders who produced < 36 estimated RIA units of antibody, it appeared that there was an excess of homozygotes for two extended haplotypes [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7]. This finding suggested that a poor response was inherited as a recessive trait requiring nonresponse genes for HBsAg on both MHC haplotypes and was strengthened by finding a much lower antibody response among prospectively immunized homozygotes for [HLA-B8, SC01, DR3] compared with heterozygotes. In the present study, we have analyzed the cellular basis for nonresponse to this antigen by examining antigen-specific proliferation of T cells from responders and nonresponders in the presence and absence of autologous CD8+ (suppressor) cells. Peripheral blood cells from nonresponders to HBsAg failed to undergo a proliferative response to recombinant HBsAg in vitro, whereas cells from responders proliferated vigorously. This failure of cells from nonresponders to proliferate was not reversed in cell mixtures containing CD4+ and antigen-presenting cells devoid of CD8+ cells. There was no difference between responders and nonresponders with respect to the number of circulating T cells or their subsets, or the proliferative response to mitogens such as pokeweed or phytohemagglutinin or another antigen, tetanus toxoid. Our results indicate that our HBsAg nonresponding subjects have a very specific failure in antigen presentation or the stimulation of T helper cells, or both. Our evidence is against specific immune suppression as the basis for their nonresponsiveness. The failure of antigen presentation or T cell help is consistent with recessive inheritance of nonresponsiveness and suggests that response is dominantly inherited.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 53 条
[31]   GENETIC-REGULATION OF THE IMMUNE-RESPONSE TO HEPATITIS-B SURFACE-ANTIGEN (HBSAG) .4. DISTINCT H-2-LINKED IR GENES CONTROL ANTIBODY-RESPONSES TO DIFFERENT HBSAG DETERMINANTS ON THE SAME MOLECULE AND MAP TO THE I-A AND I-C SUBREGIONS [J].
MILICH, DR ;
LEROUXROELS, GG ;
LOUIE, RE ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :41-56
[32]  
MILICH DR, 1989, BASIC PRINCIPLES CLI, P523
[33]   THE CELLULAR BASIS FOR THE INDUCTION OF ANTIGEN-SPECIFIC T8 SUPPRESSOR CELLS [J].
MORIMOTO, C ;
LETVIN, NL ;
DISTASO, JA ;
BROWN, HM ;
SCHLOSSMAN, SF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (02) :198-204
[34]  
MORIMOTO C, 1985, J IMMUNOL, V134, P1508
[35]  
MORIMOTO C, 1985, J IMMUNOL, V134, P3762
[36]   AUTOANTIBODY TO AN IMMUNOREGULATORY INDUCER POPULATION IN PATIENTS WITH JUVENILE RHEUMATOID-ARTHRITIS [J].
MORIMOTO, C ;
REINHERZ, EL ;
BOREL, Y ;
MANTZOURANIS, E ;
STEINBERG, AD ;
SCHLOSSMAN, SF .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (03) :753-761
[37]   DETERMINATION OF LINEAR FLUORESCENCE INTENSITIES FROM FLOW CYTOMETRIC DATA ACCUMULATED WITH LOGARITHMIC AMPLIFIERS [J].
MUIRHEAD, KA ;
SCHMITT, TC ;
MUIRHEAD, AR .
CYTOMETRY, 1983, 3 (04) :251-256
[38]  
NISHIMURA Y, 1983, NATURE, V298, P347
[39]   ALTERATIONS IN THE IMMUNE-RESPONSE OF NONRESPONDERS TO THE HEPATITIS-B VACCINE [J].
NOWICKI, MJ ;
TONG, MJ ;
BOHMAN, RE .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1245-1248
[40]  
OHTA N, 1983, J IMMUNOL, V131, P2524